Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bryan J. Cassaday Insider Profile
4 Followers
Bryan J. Cassaday, CFO at Carmell Therapeutics, holds 35.50K shares in Carmell Therapeutics (Ticker: CTCX). Most recently, Bryan J. Cassaday Bought $475 shares of Carmell Therapeutics on Sep 10, 2024 for an estimated value of 218.50.
Profitable Transactions
0 out of 6 Profitable Transactions
Average Return
-64.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Bryan J. Cassaday's holdings
Insider Roles
CFO
Roles that Bryan J. Cassaday holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bryan J. Cassaday
Bryan J. Cassaday's Trading History
List of latest transactions for each holding click on a transaction to see Bryan J. Cassaday's performance on stock
You May Also Like
Bryan J. Cassaday insider profile FAQ
What is the percentage of profitable transactions made by Bryan J. Cassaday?
The percentage of profitable transactions made by Bryan J. Cassaday is 0%.
What is the average return per transaction made by Bryan J. Cassaday?
The average return per transaction made by Bryan J. Cassaday is -64.10%.
What stocks does Bryan J. Cassaday hold?
Bryan J. Cassaday holds: CTCX stocks.
What was Bryan J. Cassaday’s latest transaction?
Bryan J. Cassaday latest transaction was an Informative Buy of $218.50.
What was Bryan J. Cassaday's most profitable transaction?
Bryan J. Cassaday’s most profitable transaction was an Informative Buy of CTCX stock on September 10, 2024. The return on the trade was -12.50%.
What is Bryan J. Cassaday's role in Carmell Therapeutics?
Bryan J. Cassaday's role in Carmell Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.